Responses
Regular and Young Investigator Award Abstracts
Clinical Trial In Progress
637 INB-200: Phase I study of gene modified autologous gamma-delta (γδ) T cells in newly diagnosed glioblastoma (GBM) patients receiving maintenance temozolomide (TMZ): immunobiologic correlative data
Compose a Response to This Article
Other responses
No responses have been published for this article.
